This inventor holds 1 USPTO granted patent. Top assignees: Ordos Clinical Medical College of Inner Mongolia. Medical University, Peking University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 667 
Years Active: 2026
Title: Huiwen Li - Innovator in Biomedical Materials
Introduction
Huiwen Li is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biomedical materials, particularly through his innovative work on fluorescent contrast agents. His research focuses on enhancing diagnostic techniques for cancer, specifically lymph node metastasis.
Latest Patents
Huiwen Li holds a patent for a fluorescent contrast agent with a targeting function, which is detailed in his invention titled "Fluorescent contrast agent with targeting function, and preparation method and use thereof." This invention belongs to the technical fields of nanomaterials and biomedical materials. The fluorescent contrast agent, known as MR780 NPs, is designed to specifically bind to CD206 on the surface of tumor-associated macrophages (TAMs). MR780 NPs accumulate in lymph nodes invaded by tumor cells and undergo an oxidation-reduction reaction with reduced glutathione in a tumor microenvironment. This reaction triggers a fluorescence signal, allowing for the diagnosis of lymph node metastasis (LNM) of breast cancer. The agent aids in preoperative evaluation, assists in clinical determination of tumor staging, and facilitates accurate resection during surgery through intraoperative fluorescence navigation. Huiwen Li has 1 patent to his name.
Career Highlights
Huiwen Li has worked at prestigious institutions, including Peking University and the Ordos Clinical Medical College of Inner Mongolia Medical University. His work at these institutions has allowed him to advance his research and contribute to the field of biomedical materials significantly.
Collaborations
Huiwen Li has collaborated with notable colleagues, including Shumin Wang and Xiaolong Liang. These collaborations have further enriched his research and innovation in the field.
Conclusion
Huiwen Li's contributions to the development of fluorescent contrast agents represent a significant advancement in cancer diagnostics. His innovative work continues to impact the medical field positively, enhancing the accuracy of cancer detection and treatment planning.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile